LGM
ASMB icon

Logos Global Management’s Assembly Biosciences ASMB Stock Holding History

Logos Global Management’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-15,667
Closed -$3.85M – 45
2019
Q4 		$3.85M Buy
+15,667
New +$2.89M 0.95% 28

Other funds holding ASMB

CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Logos Global Management's ASMB Position: Q1 2020 in Review

Logos Global Management sold out of Assembly Biosciences (ASMB) in Q1 2020, closing a stake of 15,667 shares — an estimated $3.85M sold.

Logos Global Management first reported a position in ASMB in Q4 2019 and held it in 1 quarter. The position peaked at $3.85M in Q4 2019. 98 funds tracked by Wall St. Rank hold ASMB as of Q1 2020.

  • Logos Global Management reported no remaining Assembly Biosciences position as of Q1 2020 after selling out during the quarter.
  • Logos Global Management sold 15,667 Assembly Biosciences shares in Q1 2020, an estimated $3.85M.
  • Logos Global Management first reported a position in Assembly Biosciences in Q4 2019 and held it in 1 quarter.
  • Logos Global Management's Assembly Biosciences position peaked at $3.85M in Q4 2019.
  • 98 funds tracked by Wall St. Rank held Assembly Biosciences as of Q1 2020.

Based on Logos Global Management's 13F filing for Q1 2020, filed 15 May 2020.